A Phase 3b Open-label Study of S-888711 in Thrombocytopenic Patients with Chronic Liver Disease
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Shionogi
- 14 Nov 2017 Status changed from active, no longer recruiting to completed.
- 11 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Jun 2016 New trial record